Table: begin end state 1 27 cytoplasmic 28 49 transmembrane 50 54 non-cytoplasmic 55 72 transmembrane 73 76 cytoplasmic 77 97 transmembrane 98 102 non-cytoplasmic 103 123 transmembrane 124 131 cytoplasmic 132 154 transmembrane 155 185 non-cytoplasmic 186 204 transmembrane 205 210 cytoplasmic 211 233 transmembrane 234 252 non-cytoplasmic 253 276 transmembrane 277 296 cytoplasmic 297 316 transmembrane 317 335 non-cytoplasmic 336 367 transmembrane 368 385 cytoplasmic 386 415 transmembrane 416 434 non-cytoplasmic 435 452 transmembrane 453 522 cytoplasmic
Input: >Pf1N1B4_1905 MAFPSRHSLFPFLTWLPRQTRASVGRDLIVGLSGAILALPQSIAYALIAGLPPEYGLYAA IIPVLIACLWGSSWHLICGPTAAISIVLYASVSPLAVPASQDYVTLILLLTLLAGIFQWL LGLLRFGALVNFVSHSVVLGFTLGAAVVIAIGQLPNLLGLDVPNQATALNSLLLLFSHLS EVDKPSLVLGLATVGVGIALKLLVPRWPTLLIALALSGLLVWLWPAMFGHVQLVSAFVGR LPPFSPLPLDLDLVLRLLPSAVAVGMLGLVTSLSIARSLSARSQQLLDANQEVRAQGFSN MVGAFFSGSLSAGSFTRSALSYDAGACSPLAGVFSAMWVALFAIFGAVLIAHIPIPAMAG SILLIAWGLVDHRGIRALLRVSRAEFLVMALTCVATLLLELQTAIYAGVLASLFFYLKRT SQPRVQHWREGDEDILRVGGSIFFGASHYLQVRLQRMHGARVVIEAQQINFIDYSGVEML HQEARRLLRQDRSLTLRRARPQVVEELRKLEGAEKCPIRFED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server